Item 3 on the agenda is the budget process. I welcome our adviser, Andrew Walker, who will assist us during this evidence-taking session. I refer members to the letter from the minister that has been circulated, which updates the committee on progress on implementation of its earlier recommendations. I welcome the minister to the meeting, together with Peter Collings, the director of performance management and finance in the Scottish Executive Health Department, and Julie Wilson from analytical services in the same department—hello again.
Last time I was here for two and a half hours without a break, so this will be an improvement.
If we have you for two and a half hours, we will keep you for two and a half hours. For the convenience of members and the minister, there will be a break between items.
The annual evaluation report states that 12 of the 14 health targets are on course to be met. There is good evidence to support that claim for the targets to reduce premature mortality, but the evidence is much less compelling for the other targets. What is the basis for the claim that targets are on course?
It would be good for us to be challenged on the targets that are not on course. As the member points out, the health improvement targets are very much on course. At the weekend, there was considerable coverage of issues relating to coronary heart disease and stroke, but there is no doubt that the trend is that we are making significant reductions in mortality in people under 75. That is a legitimate issue to target. Obviously, we want fewer people overall to die from the big killer diseases, but the older people are, the more likely that is to happen. The particular tragedy of health in Scotland is that so many people have died prematurely from those illnesses.
I will assist Helen Eadie by passing her a copy of the AER.
I refer the minister to the following target:
We certainly think that we are on track. Problems were flagged up in the Audit Scotland report of January 2003, which showed that more than 20 per cent of hospitals had a clear need for improvement. In each case, the hospitals have agreed action plans with external auditors and the latest indications are that progress is being made. I am not in any way complacent about the situation, but all the indications are that improvement is being made in that area.
I did not understand the answer. How do you measure that? Many people are very concerned about hospital-acquired infections. You say that progress is being made, but how do you know where you are starting from or where you ought to be to show that progress has been made? How do you measure progress?
We are highly dependent on NHS QIS, which is the body that is incorporating the Clinical Standards Board for Scotland. It goes round hospitals and makes reports. In relation to clean hospitals, Audit Scotland has a role as well. We set the target against the reports of those bodies. We are not making the judgment; the external bodies that produce the reports and carry out the assessments do that.
They are doing the reports and the assessments, but you are the minister, so you have to set some kind of target. Am I correct? You need to say, "That is not good enough; the target has to be such-and-such." I am trying to establish how you measure progress. How do you know that it is being made?
If one is making steady progress towards a final standard that has been set by those external bodies, that is an acceptable way in which to proceed. The idea of having continuous improvement is good, as long as one measures it and can demonstrate progress. In this case, the ultimate yardstick is the standards that have been set by those external bodies. We are measuring progress towards those standards.
Has a time limit been set for meeting those standards?
We are talking about significant progress. We have not set a timescale for the achievement of absolute perfection; we are saying that we want there to be steady progress towards meeting those standards.
You started off by talking about the comment in the media at the weekend about coronary heart disease. I want to ask you a general question about that. It was highlighted that there has been a rise in the number of men who suffer from coronary heart disease and a rise in the number of women who are dying of strokes. Target 1 in the AER is on coronary heart disease and target 3 is on stroke. If those trends continue for the next year or two, where does that leave your key targets—targets 1 and 3?
The first thing to say is that, genuinely, we must consider trends rather than figures for one year. The figures to which you refer were not to do with under-75s, although that is not to say that we should not consider them carefully. The reality is that, although the increase that you have flagged up related to the incidence of CHD among all men in one year, the trend is still very much downwards. I think that there has been a 23 per cent reduction in the incidence of CHD over 10 years and a 30 per cent reduction in mortality. The position is similar for stroke—the trends are still downwards, notwithstanding the upwards move in one year.
The British Medical Association gave us some written evidence that casts doubt on one or two of the minister's targets. There are three examples that I would like to run past him, and he hinted at one of them earlier on. The BMA says that, under the general medical services contract for general practice, offering 48-hour access is optional for general practitioners. It asks why the Executive has a national target and why it is committed to meeting it when the scheme is voluntary.
The BMA has been making that point about that target for a long time, but I have met a large number of GPs—most recently, two weeks ago at the primary care collaborative—who are seriously engaged not only in meeting the target but in surpassing it. The evidence that I am getting, not just from GPs but from the whole primary health care team, is that that is not only good for patients but is incredibly good and motivating for the staff who work in general practice. By changing the booking systems and taking a team-based approach to care, they are finding that the stress and difficulty of their job are considerably lessened. Doctors and other primary health care professionals on the ground are enthusiastic about that. I know that the BMA is still officially against the target, but I merely make the distinction.
My point is that many of them are trying to deliver anyway, regardless of whether the Executive has a target. If you put an incentive in place, it is for them to take it up or not to take it up. That is what an incentive is; it is not a stick. Perhaps what they are worried about is that a target may be seen more as a stick than as anything else.
The target is for 2005, but I suppose that one of the functions of targets is to focus people's efforts and priorities. In the case of cancer treatment, the target is very much directed at ourselves. As you know, there is a massive programme on cancer, involving the cancer strategy and building up staff and equipment capacity for diagnosis and treatment. We are in the middle of a big cancer strategy implementation, so we believe that we can meet the target. As I indicated, we are making significant progress towards it.
You mentioned 2005. Is that a hope or is it a prediction of when the target will be delivered?
That is what we are aiming for and we believe that we can achieve it.
My final question is on smoking cessation. The BMA says that the target of a 2 per cent reduction is really not on. Why is the target not something like 10 per cent? Are you likely to stiffen your resolve and set a higher target?
At the moment, we are doing better than that. I am open to your suggestion that we could set a stricter target, as I hope that we will achieve better than that. The target was set some time ago, and I accept that we want to do better than it. Current indications are that we are doing a bit better than that.
Are you likely to consider changing your targets at the end of the Executive's consultation on smoking cessation, which will take place over the summer? Are you waiting to get that through?
There is on-going consideration of that target, as there is of other targets.
I have a tiny follow up to that. How do you measure smoking reduction?
I cannot answer that question in detail because I do not know.
I have a small supplementary question, seeking clarification. The target that David Davidson mentioned was to wait for no longer than two months from urgent referral to treatment, so the referral would have to be urgent. Can you define that?
That would be down to clinical judgment.
So some people might wait considerably longer.
Yes.
Waiting times will always involve on-going discussions with health boards, as you said last week. Has the time not come to confirm patients' rights to minimum waiting-time guarantees?
We have progressed significantly on the issue by giving guarantees beyond what applies in the rest of the United Kingdom, although I believe that similar guarantees apply in England for patients with heart disease. We have extended that to all in-patient treatment and to heart surgery and other heart procedures such as angioplasty and angiograms. That significant progress has taken place only this year. It is the correct way forward and it appears to be bearing fruit.
In its evidence, the Royal College of Nursing suggested that the target of 12,000 more nurses by 2007 will not be sufficient. One of its key arguments is that the target does not take account of those leaving the profession. If you believe that you are on course to meet the present target, is there not an argument for making it more ambitious, for example by taking into account those nurses who are leaving the profession, so that the 12,000 nurses are additional?
No one is saying that we could get 12,000 additional nurses within that time. However, there is an unprecedented increase in the number of additional nurses entering the NHS. For example, last year a net increase of 1,000 extra trained nurses entered the NHS. We have figures on that and it is unprecedented in the Scottish NHS no matter how far back we look.
If the target was phrased in terms of a net increase, how many thousand additional nurses would be recruited by 2007?
As I say, it is confusing when we are talking about nursing. Sometimes we talk about qualified nurses; sometimes we talk about the whole nursing work force, including health care assistants. If we focus on qualified nurses, 1,000 extra nurses was the highest number of extra nurses ever achieved in the history of the NHS in Scotland. Obviously, we want to improve on that, year on year, but, because 1,000 is the most extra qualified nurses that we have ever had, I think that a 12,000 net increase is unrealistic. We want to build on the position. I would not pluck a figure out of the air at this meeting, but we are continuing discussions with the RCN to try to establish agreement about the net increase that would be required.
It is important that we keep nurses within the NHS. Our new nurses are learning and do not have the experience, so it is extremely important that we keep the ones who have knowledge within the system.
I agree that that is an important part of retention. I do not have figures for that in my head, but I can find out whether such figures exist. If they do, I will communicate them to you. Grievances are one area to address; health issues are another. Someone who attended one of my surgeries recently told me that, because of things that had happened to her, she needed occupational health support to go back to work. We need to consider all the issues relating to the retention of nurses—that is the correct way in which to proceed anyway if we are to value nurses. If we have the figures for which you have asked, I will certainly communicate them to you.
That would be useful for the committee, as we are about to embark on an inquiry into recruitment and retention in the NHS. Any information that we do not have to dig for will be gratefully received.
First, on the question of retention, you must have been disturbed by the reports over the weekend and the effect that they will be having on the morale of nurses and staff in the NHS. It has been suggested that the hard-working staff in the health service are about to lose substantial earnings. What is your comment on that?
I hope that there is nobody in the latter category.
We will consider that in our work-force planning review, in which we will bring some vested interests into play.
On your first point, I was slightly puzzled by the story in the Sunday newspaper. There are two main unions involved, but the reality is that the Royal College of Nursing has voted to support agenda for change by a 9:1 margin. The simple reason for that is that the vast majority of nurses stand to gain from agenda for change.
We appreciate that, minister.
You said that money is available. When was the budget set? Given the drive and acceleration of the acute services review and the centralisation programme, does the budget reflect what we need to do now? Many of our communities will increasingly depend on specialist and consultant nurses to deliver local services, which are very much in demand. Do we need to review the budget? Do we need to accelerate the process if we are to meet—even halfway—the demands of the communities that we represent for delivery of local health services?
We certainly need to keep reviewing and accelerating those programmes. I met the new chief executive of NHS Education for Scotland within the first week of his taking up his post in April. I thought that it was important to do that because NHS Education for Scotland is a key organisation. I spoke to him about specialist registrars, which is the level below consultants, to make sure that the expansion in that important area would take place during this year.
Can you provide more detail about the moneys that are being allocated and whether there are any plans to accelerate the provision of those moneys? What discussions are taking place with the various organisations to bring about that change in numbers and to effect a change in the duties that people can perform within the health service? How quickly will those changes take place?
In addition to that, minister, do you have information—I appreciate that it may not be available or may not be able to be retrieved—on how many nurses leave the NHS to go into private commercial operations? Do you know how many NHS nurses become agency nurses? I would quite like to have that figure to see whether, instead of leaving the NHS entirely, people are coming back into the service at more costly rates.
That is certainly a big issue and we will provide the committee with the figures that we have on it.
One way of attracting people into the health care professions is to provide access to continuing professional development. Does the minister sympathise with the RCN's desire to have three days of CPD each working year? Is there money in the budget to cover that?
We have not made a specific commitment on three days' CPD. At the moment, we have said that everyone is entitled to CPD. For nurses, in whom the RCN has an interest, we have dedicated annual funding to boost CPD by providing an extra £1.7 million a year over and above the existing CPD budget. Over the past couple of years in which that money has been provided, there has been a large expansion in CPD opportunities for nurses. However, we have not made the particular commitment that you mentioned.
I understand that specific moneys have been provided, but the nurses are seeking to be paid for those three days of CPD. In other words, the CPD should be done during working time. The health boards will require resources if they are to be able to provide that. Is there any money for that within the system?
The extra money that has been provided allows people to be released from their work to attend CPD, so that should not be an issue in the nursing initiatives that we have supported.
Can we have a breakdown of those figures?
If you want detailed information on how the £1.7 million has been spent, I can send it to the committee.
That would be helpful.
For the record, it is important to clarify that the concern about the target was raised by the RCN, which had been led to believe that the target was to recruit an additional 12,000 nurses.
I am perfectly willing to acknowledge that England is ahead of us in certain areas. I have been up front about that in relation to nurse consultants. It was a great frustration to me that so little progress on nurse consultants was made before the election. That is why I told the RCN conference a year ago that we would triple the numbers of nurse consultants from 18 to 54. I think that 27 are on the ground now, but I do not have the figure in front of me. More important is that a lot of other posts are being planned. Obviously, it takes some time to work up the details of the posts. We have made reasonable progress in the year since the election and we are on track to meet our objective.
The RCN is worried that filling the nurse consultant posts would lead to a shortage of other nurses. We cannot keep replacing doctors with nurses, because that would lead to a deficit of nurses to do the rest of the work that nurses used to do. The RCN flagged up that point in some of the documents that I read and I understand why it has concerns.
The minister has already undertaken to try to provide the committee with statistics on the number of nurses who leave due to stress.
That is an issue, too, but the problem is also about employing enough nurses. I have spoken to nurses who have said that extra nurses are not allowed to be hired because of financial constraints on health boards.
There are financial issues. I agree substantially with what Jean Turner has said. Nursing issues have been important to me throughout my time as Minister for Health and Community Care. We are making progress, but the RCN and others say that we need to make more progress. We had a constructive meeting with the RCN, which is—along with Unison—fully involved in the facing the future group. We are addressing the issue in partnership.
This may be a very stupid question—it probably is and I probably should not ask it because it will make me look stupid—but is there any guidance on the number of patients per nurse? I understand that there are other intricacies. There may be guidance on the number of patients that a general practitioner can have, but is there guidance about that for nurses?
That is precisely the kind of territory that the work-load report went into. Sometimes, different hospitals use different systems and the work-load group has tried to introduce more standardisation and greater consistency. However, it would not be possible to give an overall ratio of nurses to patients. Intensive care is an obvious example of the fact that different kinds of wards require different numbers of nurses.
Is that being looked into?
If we have not sent you a copy of the work-load report, we should send you one. That report is, if I may say so, relevant to your more general work on the work force.
We do not have a copy, but one would be very useful.
Minister, we have heard what various organisations think of the national targets. Is this a good time to review those targets? Is there scope to change the emphasis? Last year, you suggested to the committee that two of your priorities would be service redesign and public involvement. I accept, as I think others do, that those issues affect existing targets. Do you agree that targets have to be realistic and flexible and that they have to be constantly assessed so that new priorities can be introduced? Targets that have been reached can be dropped. What kind of work is your department doing to evaluate targets and to change them?
The targets are for this spending review period—which is three years officially, but tends to be two or three years. Obviously, we are now considering the next spending review period. You make some fair points; we are certainly considering how we can achieve what the committee, in its recommendations, correctly calls "SMART" targets for public involvement and patient focus. The agenda is not just about the wider public; it is specifically about patients and their involvement. Achieving specific, measurable, achievable, relevant and time-limited targets for that is challenging, but I accept in principle that we should have such targets. We will certainly try to have them for the next spending review. I am not saying that the present targets are the final targets, because the situation is evolving. I do not disagree with the principle of what you say.
For the next spending review, will you be giving the committee information on how you intend to involve the public and the committee before targets are set or will we just hear about the targets when they have been set?
That is an interesting process issue to do with the spending review, but it is not really one for me to answer. As you know, an announcement will be made in the autumn. The arrangements will be the same across the Executive. Peter Collings will know about that.
Minister, did you say that the targets are not for you—
No—the targets are for me. However, Duncan McNeil's question was on the process of how spending reviews are developed and how committees are involved.
I thought that he was asking about input from the committee and the public in respect of those targets, rather than about processes. He was asking about substantial input.
Convener, I was picking up the minister on his point that there could be a role for the public and the committee in engaging in discussions on the targets that are to be set. The minister has certain priorities, but other priorities have been set by society in general, I suppose. How can we influence the process?
I was just making a point about the process of the spending review, which we are obviously already well into. I do not know what the involvement of committees in that process will be. I have no doubt that I should know, but I do not know what the Minister for Finance and Public Services has said about the matter. Peter Collings may be able to help.
Thus far, the engagement has been between the Minister for Finance and Public Services and the Finance Committee, rather than between him and committees more generally. We expect an announcement in September. If committees have views, it would clearly be extremely helpful to hear them before the summer recess.
Our budget adviser has been working to obtain financial plans from health boards for the current financial year. It is unfortunate that, although we are more than a month into the current financial year, we have been able to obtain only three such plans. That seems to be a recurring problem—at the beginning of previous financial years we have been unable to see the financial plans for all health boards. What are your views on that? Do you have any mechanisms in place to ensure that the situation does nor recur year on year?
We discussed that issue the last time I was before the committee, when we talked about the fact that things are out of synch. We are looking at the budget for 2005-06 and the plans that you have or have not received are presumably for 2004-05. However, no doubt you are saying that you would have liked to have had more plans from health boards for this year. I know that there has been at least one meeting with some committee members, if not all committee members, and Andrew Walker on getting more information from health boards. Peter Collings and Julie Wilson may wish to comment on those issues.
The meeting was with the deputy convener and me.
The reason why the committee has not received more plans is that a number of boards are still working on their budgets for this year. They do a first cut of the figures early on, but they are still evaluating how much pressure there will be, what developments they can afford and what savings they need to look for—there is a moving target.
Following the meeting at the beginning of March, we provided Dr Walker with all the information that we currently hold on the breakdown of the money into care programmes. It would be beneficial for the committee to examine what is spent on that basis. Once we have all the financial plans, we can link them together, to give the committee the past trend and the projection. On finances, the local health plans have a tie-up element at a very aggregate level.
I welcome that helpful offer. Dr Collings, when will you be able to give us the information that you mentioned?
I hope to have it in June, but where boards are in the process varies. We are pressing them to provide us with the information but, as you will be aware from reports of health board meetings and the papers, some of them are still reshaping the budgets for this year. It is hard to judge, but I hope that we will have the information in June.
We have seen only three financial plans, but they predict financial shortfalls that will be covered by non-recurring money or cost-recovery programmes that will affect front-line services. People are concerned that front-line services may be affected by recovery plans to address deficits that have built up over a period of time. Does that give you cause for concern? How do you plan to address that issue when you see the recovery plans of the boards that are in deficit? Indeed, some boards face a substantial deficit.
Peter Collings can provide more detail, but I think that three boards are in deficit.
It appears that some of the larger boards are hoping to recover moneys from the smaller, neighbouring boards to which they provide services. The recouping of such money appears to be part of the larger boards' recovery plans, but it places more financial pressure on smaller boards. Will you comment on that?
I presume that you are talking about money for cross-border flows of patients. There have been issues about that and I think that we are making progress, but perhaps we need to make more progress. Peter Collings will talk about that in more detail.
There is a range of issues in relation to that matter, one of which is whether the major teaching boards are adequately compensated for the complexity of the cases that they deal with when they take patients from other board areas. A lot of work has been done on that in the east of Scotland, where arrangements are fairly stable. In the west of Scotland, there remains a debate about whether compensation is adequate.
Minister, you appoint health board chairmen and you meet them regularly—I think that you meet them monthly. What guidance or instructions did you give chairmen in advance of their preparation of financial plans for this year?
Again, Peter Collings can respond to that, because a lot of that work happens at chief executive level, as well as at chair level. Obviously, all boards must live within the resources that they are given; that is a key issue in health management and a primary duty of the chief executives—who are the accountable officers—even more than it is of the chairs. Within that context, boards have to take account of the priorities and targets that need to be met, which must be uppermost in their minds when they plan for forthcoming years. Obviously, we give them as much information and intelligence as we can about the various pressures that build up in the system.
The other point that we made, with which the boards completely agree, is that it is important to try to find savings on non-clinical costs. For example, there are savings on overhead costs from the move to single-system working and we are working with boards to see whether we can achieve substantial cost reductions in NHS Scotland by aggregating procurement. We have said that those areas are the first places in which they should look for savings.
So that guidance has been given by Dr Collings's department to—
Those points were made at meetings with the chief executives. As well as meetings with chairs, the department has monthly meetings with the chief executives, which are chaired by Trevor Jones as chief executive of NHS Scotland.
Does the minister's response mean that, in the main, he leaves it to the civil servants to deal with the mechanics, or has he given any specific details on the outcomes that he is looking for next year?
Obviously, the priorities and targets are set by ministers, so at that level there is full involvement. I take a great deal of interest in the state of the finances because, at the end of the day, money is required for all that we want to deliver. I am conscious of the issues and we talk about them at the meetings with chairs. A greater level of detail is gone into at the meetings with chief executives, but that is consistent both with what is said at the meetings with chairs and with the ministerial priorities and targets.
You said that three health boards are in some financial difficulties, but there could be more; Peter Collings said in his evidence that there are seven others that could go either way. You said that you do all that you can to help boards, but surely the matter comes down to one of two things. If you are fully funding the new responsibilities and boards are unable to manage with the money that you give them, there must be gross financial mismanagement at the local level. If that is not the case, the opposite must be true, namely that you are not fully funding the new responsibilities and boards therefore have to make cuts elsewhere—those cuts form the basis of the recovery plans—to meet the responsibilities. It has to be one or the other and, from the evidence of the health boards, I think that many elements of the new responsibilities are not fully funded. That must surely have an impact on the targets that you set, in that the health boards' ability to deliver on the national targets is compromised because they have to cut back on some of the service developments that would help them to meet those targets.
I think that Peter Collings will want to comment further on the seven health boards. The general point that you make relates to the way in which money is distributed to boards. We do not add up all the responsibilities of a board, aggregate the figures then give out the funding—money is not distributed to boards in that way. In the Scottish Parliament, there is three-year budgeting and, in historical terms, generous health budgets have been set. There are a lot of pressures in the system, but that is the way in which budgets are set. Within that, people have to make local decisions about priorities.
On the numbers that the seven health boards have sent us so far, I cannot say at the moment whether those boards will end up a little bit over or a little bit under budget, because they are sufficiently close to spending exactly to budget. As at the end of last year, they are not at risk of the numbers suddenly changing so that they are badly in deficit.
I would like to check one more thing. Is it your assertion, minister, that the new responsibilities that are now on health boards vis-à-vis the contracts and so forth are fully funded by the Health Department?
As I say, money is not distributed in the way that you suppose is the case. It goes out as a block to boards, from which they have to meet their various responsibilities. The money is not worked out by adding up all the different responsibilities of the health boards. As you know, we have three-year budgeting in health and the decision on funding was made at the time of the spending review, just as in September we will make an announcement about health funding over the next few years. That is the basis of health funding.
If I may, I will give an example of something that has been brought to my attention. In Glasgow, for example, the £77 million of new money has been used for pay and price inflation, including for the new contracts. There is nothing left for anything else—nothing for your targets. The money has simply been put into staffing—there is a direct correlation. If it is possible to say how much is going to cover pay increases, inflation and the required staffing levels in Glasgow, it must be possible to do that in other health boards.
I am not quite sure how many other pressures are included in that figure. It is reasonable for the committee, in seeking information from boards, to ask exactly how much of the new money has been spent in a particular way. I do not know whether we have that information from all boards at the moment.
My adviser tells me that we have that information from three health boards. What we are trying to get at is the simple question whether boards are getting into greater deficit because they did not get enough money to cover inflation, staffing and everything else that arose as a consequence of the new contracts. The examples from Glasgow and two other health boards show that there is a direct link.
In the case of Greater Glasgow NHS Board, one of the issues is its decision last year to fund some costs out of non-recurring money. To that extent, the situation in Glasgow is not the same as that of the other health boards.
We might return to the issue as soon as my adviser stops frowning and comes back with a supplementary.
The other thing that I noticed about Glasgow is that although it had a lot of publicity for the things that it was not able to do, it was some of the service development that it wanted to build into its plans that resulted in the consequential reductions in other areas.
That is right. That is the point that is being made. After it had dealt with inflation and staffing costs and so forth, Glasgow did not have the money for anything else.
That is not quite the point that I made.
We will leave it at that. We can look at the Official Report and see what was said. No doubt I will be given further advice on the subject.
I have to say that I am not very happy with the answers that the minister has given, particularly to the last set of questions about the additional pressures on NHS boards. As the issue is one that I have raised with the minister before, I suspect that he will not be surprised that I am doing so again.
I am sorry that I have given the impression that you describe. I did not intend to and I think that I have said on several occasions this afternoon that there are particular pressures this year because of the introduction of the new contracts and that I will do everything that I can to deal with those pressures within the budgets for which I am responsible.
We are asking for financial plans from health boards, but they do not know what their finances are going to look like. They do not know whether they are going to be given extra money to meet the additional pressures. Do you think that that is an acceptable way to have to run major organisations that are trying to deliver key policies of the Government?
That is precisely why I hope to find some extra money for them in the near future. I want the boards to be able to take that into account throughout the year. Equally, however, they have to examine their budgets seriously. Obviously, we do not want patient care to be affected in any way as we want to improve and develop it but, as Peter Collings said, boards need to examine seriously the money that they are spending on services in other, non-clinical areas. We have a big agenda in the Health Department involving shared services and saving money through the way in which we deliver non-clinical services.
How was the £30 million distributed? Who got it for what?
The Arbuthnott formula was used.
Can you provide the committee with an estimate of what the new contracts will cost each board? As we have said, the boards are just meeting policy requirements. I ask Kate Maclean to develop that point. I would like the minister to clarify the situation.
That is interesting. Obviously, money has to be distributed using a certain formula, but in other Executive policy areas distribution of money has not been equal in all local authorities, despite the fact that a formula was used. I refer to the McCrone settlement for teachers and the concessionary travel arrangements. Does the same apply to this money, which has been distributed specifically to fund consultants' new contracts? Would it not be better to distribute the money based on how many consultants there are in each health board area, rather than on the Arbuthnott formula? I know that there have been complaints in the past.
The money has not been distributed specifically to fund the consultant contract. You make an interesting suggestion. Given that the consultant contract is subject to individual job plans with every consultant in Scotland, the issue is not just the number of consultants but how many sessions they negotiate with boards. Distributing the money on the basis that you suggest would be a very complex procedure. I know that you have questions about the Arbuthnott formula, which you may ask later, but I still think that it is the fairest means of distributing the money.
It would be interesting for us to know how many consultant sessions will be provided per health board, rather than how many consultants each board employs, and how much of the additional £30 million each board has received. We could then see which boards have benefited more than others.
Because we have to produce our report next week, we will draft a letter and circulate it to members later today or tomorrow, so that they can have input to the minister and, hopefully, get a response before the report is finalised.
I am sorry to labour the issue of the consultant contract, but I want to pursue the point made by Janis Hughes. We welcome the additional money, which will relieve pressure on boards. Over recent months, boards have lobbied us concertedly about the shortfall and the disagreement about what should be paid. More important, what is in this for the patient? Although we welcome the money, it will have little impact on the patient. Today you said that the contract was worth while. When he was asked about the patient benefits last week, Peter Collings said that we must pay the going rate to retain people and that if we do not, we will not fill vacancies. He also said:
The contracts will be in place soon, but job planning is not a one-off process. The job plans will be continually revised and developed. That is why some of the advantages will take longer to come on stream. Redesigning how care is provided cannot be done in the short period of time that is required for the initial job plan.
We do not expect a big bang, but we want some confidence that we will see additional service sessions. When can we expect to see those? 2005? 2006? 2007?
We will see some benefits right away, in the sense that all consultants will be required to do seven and a half sessions of clinical care. That will start very soon, once the initial job plans have been signed up to. However, some of the other redesigning of services and roles will take a bit longer.
Why do you not just say that you do not know?
That is not the correct answer, so why should I say it? I cannot say what things will look like in 2008 and it would be completely wrong of me to do so. David Davidson and others would jump on me if I sat here and said exactly what every consultant in Scotland would be doing in 2007, 2008 or 2009. That will be subject to the job planning between local managers and local consultants. My job is to ensure that they do that job properly and that they seize the opportunities that are provided by the consultant contract. My job is not to fill out the job plan details for every consultant in Scotland.
The consultants are catching up with the junior hospital doctors, so they will certainly be paid better for what they do. Do you expect the bill for the waiting times initiatives to go down as a result? Will consultants do that additional work within NHS time or will they still get paid £500 a session to reduce waiting lists?
Waiting times initiatives will still exist, but they will be standardised across Scotland. Up till now, the way in which the rate that is paid could be inflated has been a problem in certain parts of Scotland, so there will be more standardisation on that. However, given the job planning and the new contracts, we expect that there will be less need for specific waiting times initiatives in the traditional sense.
A lot of money has gone into such initiatives, but we were surprised that the figure for Greater Glasgow NHS Board was—I think—only £2 million.
I said that the money for the GMS contract is separate from health boards' money.
If Greater Glasgow NHS Board, which is nearly £60 million in debt, has to claw back about £37 million in the first year and the rest in the second year by cutting a lot of services, patients will suffer greatly as a result of the new contract.
The money is coming from central Government—I do not think that I can add to what I said about that earlier. I recognise the pressures on health boards, but boards have known for a long time how much money they will receive. In March we supplemented that to some extent and we will seek to do so again in the near future.
I note that you said that the money for the GMS contract is ring fenced, but we must consider what boards will be expected to pay out in future. Three boards are currently in deficit and seven are hovering around break-even. What do you anticipate that the situation will be this time next year and what will you do if the budget down south does not bring the routine increases to Scotland?
We are not looking "down south", as you put it, in that timescale, because such matters are considered in terms of spending review periods, as I said, so in that sense there is no annual allocation. We know how much money we will have in 2005-06 and obviously we are trying to get the best intelligence from boards about the pressures that their systems are under. Obviously, we also have our own information and we want to take early action. It is precisely because we recognise the pressures in the system that we seek to find more money centrally to send to boards in the near future.
It might save time if you could send the committee a note to inform us how you set criteria for recovery plans and how you judge such plans. You said that everything goes out on the Arbuthnott formula, whether or not there is a problem, but different boards will have distinctly different problems.
I am sure that Peter Collings can provide that information. He could speak at great length on the subject, too, but you have not asked him to do that.
It is nice to hear you admit that. I was not giving a view; I just wanted to find out what your view was.
You raise a series of issues. We have a new system and we have made significant progress in expanding the role of the SMC so that new drugs can be considered well in advance. Chief executives and others are involved in the SMC, so boards have quite a long lead-in time if a new unique drug is recommended for use throughout Scotland. Planning has improved in the past year and we have tried to address postcode prescribing, which has been a big issue for the Health Committee and the Health and Community Care Committee over the years. We think that we have made significant progress.
Are you saying that clinicians have the right to prescribe in the best interests of their patients, as long as a drug has been approved, so boards must live with that?
That is absolutely the case, yes.
Thank you. We will have a short break.
Is that the end of questions on the budget?
Yes. The next item will be consideration of your letter of April 2004 on the appointment of an expert group to develop a national framework for service change in the NHS and the final item will be hepatitis C.
Meeting suspended.
On resuming—